Bollard Group LLC Dexcom Inc Transaction History

Bollard Group LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$112.47 - $130.98 $2,249 - $2,619	20 New	20 $3,000
Q4 2020 Feb 04, 2021	SELL	$78.0 - $104.5 $31,200 - $41,800	-400 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$62.68 - $105.34 $12,536 - $21,068	200 Added 100.0%	400 $162,000
Q1 2020 May 14, 2020	BUY	$47.79 - $75.63 $9,558 - $15,126	200 New	200 $54,000
Q2 2019 Aug 13, 2019	SELL	$27.84 - $38.92 $5,568 - $7,784	-200 Closed	0 $0
Q4 2018 Feb 05, 2019	BUY	$26.99 - $37.37 $5,398 - $7,473	200 New	200 $24,000

1,084

352M

8.45M

5.75M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $33.2B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Bollard Group LLC, based on Form 13F filings with the SEC.

Stay updated on Bollard Group LLC with notifications on news.